Description
The goal of the research is to identify treatments or interventions that can be used on people across age, ethnicity, gender, and lifestyles. If the clinical trial does not represent the population that will ultimately benefit from the study findings, then we won’t have an accurate picture of the efficacy and safety of these treatments in the real world.
However, it is a known issue that many clinical trial populations do not represent the population that will ultimately benefit from the study treatments or interventions.
This course will cover the ethical considerations of diversity and inclusion in clinical trials, identify barriers to diversity in research, share practical examples of what diversity in trials could look like and how to increase diverse participation, as well as how to track the effectiveness of your D&I initiatives.
Objectives
By the end of this course, learners will be able to:
- Articulate the scientific and ethical importance of increasing diversity and inclusion in clinical research.
- Identify why diversity-related goals of sponsors and study sites can differ.
- Recognize the several different barriers to participation for under-represented populations in clinical trials.
Certificate
By completing/passing this course, you will attain the certificate Advarra Completion Certificate
Shopping Cart
Your cart is empty